Collegium Pharmaceutical, Inc. Common Stock (COLL) — Analysis Summary
Collegium Pharmaceutical, Inc. Common Stock (COLL) has a market cap of $1.11B with year-over-year revenue growth of +23.6%. Net margin stands at 8.1%. The stock trades at a P/E ratio of 14.8.
Key Takeaways
- Revenue changed +23.6% year-over-year
- Net margin of 8.1%
- P/E ratio of 14.8
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, COLL posted revenue growth of +23.6% and trades at a P/E of 14.8.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.